The global hemato oncology testing market size was estimated at USD 3.60 billion in 2024 and is projected to reach USD 7.44 billion by 2030, growing at a CAGR of 12.99% from 2025 to 2030. Hemato-oncology pertains to the diagnosis, treatment, and prevention of blood-related cancers and hematologic disorders, including conditions such as leukemia, lymphoma, and myeloma. Several key...